151-165 of 266
The Future of Clinical Sequencing: Whole Genome vs Exome Applications in Clinical Care
Genetically SpeakingThe Future of Clinical Sequencing: Whole Genome vs Exome Applications in Clinical Care
Richard Gibbs, PhD
Robert C Green, MD, MPH
Ethical Issues in Genetic Testing: the Who, What, Where, How and Why of Sequencing Information
Genetically SpeakingEthical Issues in Genetic Testing: the Who, What, Where, How and Why of Sequencing Information
Wylie Burke, MD, PhD
Howard Levy, MD, PhD
Translational Genomics and Health Outcomes Research: What's Ready for Primetime?
Genetically SpeakingTranslational Genomics and Health Outcomes Research: What's Ready for Primetime?
Howard Levy, MD, PhD
Robert C Green, MD, MPH
The Role of the ASHG in Health Professional Education
Genetically SpeakingThe Role of the ASHG in Health Professional Education
Joseph D. McInerney, MA, MS
Howard Levy, MD, PhD
Genetics and Uterine Fibroids: Understanding the Origins of Tumor Development
Genetically SpeakingGenetics and Uterine Fibroids: Understanding the Origins of Tumor Development
Howard Levy, MD, PhD
Cynthia Casson Morton, PhD
Discovering the Unseen Risks of DNA Testing
Primary Care TodayDiscovering the Unseen Risks of DNA Testing
Brian P. McDonough, MD, FAAFP
- advertisement
The Society for Maternal Fetal Medicine's Keys to OB/GYN Success
Clinician's RoundtableThe Society for Maternal Fetal Medicine's Keys to OB/GYN Success
Matt Birnholz, MD
Breaking Inter-Generational Cycles of Disease Determinism: The DOHaD Project
Clinician's RoundtableBreaking Inter-Generational Cycles of Disease Determinism: The DOHaD Project
Matt Birnholz, MD
ACMG -- The Coming Revolution in Medical Genetics
Grand Rounds Nation®ACMG -- The Coming Revolution in Medical Genetics
Matt Birnholz, MD
Familial Hypercholesterolemia: Risk Stratifications in Practice
Lipid LuminationsFamilial Hypercholesterolemia: Risk Stratifications in Practice
Jennifer Robinson, MD, MPH
Alan S. Brown, MD, FACC, FAHA, FNLA
It's Relative: Screening and Treating Familial Hypercholesterolemia
Lipid LuminationsIt's Relative: Screening and Treating Familial Hypercholesterolemia
Anne Goldberg, MD
Alan S. Brown, MD, FACC, FAHA, FNLA
Janet Wright, MD
Dan Roden, MD
- advertisement
University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3
Grand Rounds Nation®University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3
Matt Birnholz, MD
University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2
Grand Rounds Nation®University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2
Matt Birnholz, MD
University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1
Grand Rounds Nation®University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1
Matt Birnholz, MD